JPMorgan's Harian Sur maintained an Overweight rating on NVIDIA (NASDAQ: NVDA) in a note Tuesday, saying the company's healthcare vertical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE